Study details
Enrolling now
Two-Fraction HDR Monotherapy for Localized Prostate Cancer
University of California, San Francisco
NCT IDNCT05665738ClinicalTrials.gov data as of Apr 2026
Target enrollment
17
Study length
about 4.5 years
Ages
18+
Sex
Male only
Locations
1 site in CA
What this study is about
This trial is testing a treatment called high dose rate (HDR) brachytherapy delivered in two fractions, given 3 hours apart. This treatment aims to see if it's safe and effective as a single treatment option for localized prostate cancer.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive High Dose Rate Monotherapy
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Proportion of participants with treatment-related adverse events
Secondary: Mean Change in International Prostate Symptom Score (IPSS) over time